4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.
The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.
New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.
More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.
In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.
The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。